icon-folder.gif   Conference Reports for NATAP  
 
 

16thEuro

Back grey_arrow_rt.gif
 
 
 
Relative Bioavailability of Darunavir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (D/C/F/TAF) Single-Tablet Regimen When Administered as a Whole, Split, or Crushed Tablet
 
 
  Reported by Jules Levin
16th European AIDS Conference, October 25-27, 2017. Milan
 
Kimberley Brown,1 David Thomas,2 Kevin McKenney,2 Michael Reeder,3 Richard B. Simonson,1 Ceyhun Bicer,4 Richard E. Nettles,1 Herta Crauwels5
 
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA
2Janssen Research & Development, LLC, Titusville, NJ, USA
3Janssen Research & Development, LLC, Raritan, NJ, USA
4BICER Consulting & Research, Antwerp, Belgium
5Janssen Research & Development, Beerse, Belgium

1030171

1030172

1030173

1030174

1030175